Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Obesity | Research

Associations of five obesity indicators with cognitive performance in 30,697 Taiwan Biobank participants

Author: Wan-Yu Lin

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Background

Obesity adversely influences the central nervous system and cognitive functions. However, the relationship between various obesity indicators and cognitive performance remains controversial. It is unclear which obesity indicator is more relevant to cognitive impairment.

Methods

The Taiwan Biobank (TWB) administered the Chinese version of the Mini-Mental State Examination (MMSE) to 30,697 participants (12,094 males and 18,603 females) aged 60 to 70 years. A total of 3,454 (11.25%) individuals with MMSE < = 24 were classified as having poor cognitive performance. This cross-sectional study investigates the associations of five obesity indicators with cognitive performance. Five separate logistic regression models were fitted for males and another five for females. Covariates adjusted in all models included age, smoking status, drinking status, regular exercise, chronic disease status (diabetes, cardiovascular diseases, heart diseases, stroke, or Parkinson’s disease), depression status, blood pressure level, total cholesterol, fasting glucose, and educational attainment. The five obesity indicators included body mass index (BMI), body fat percentage (BFP), waist circumference (WC), hip circumference (HC), and waist-hip ratio (WHR).

Results

Abdominal obesity defined by WHR was significantly associated with poor cognitive performance. Male WHR > = 0.90 had a higher risk of poor cognitive performance than male WHR < 0.90 (odds ratio [OR] = 1.233; p = 0.007); female WHR > = 0.85 had an increased risk of poor cognitive performance compared with female WHR < 0.85 (OR = 1.221; p = 3.9E-4). HC and general obesity (defined by BMI and BFP) were not significantly associated with cognitive performance.

Conclusion

The results consistently agreed that preventing abdominal obesity is associated with better cognitive performance in both males and females.
Appendix
Available only for authorised users
Literature
1. Fredriksen-Goldsen KI, Jen S, Bryan AEB, Goldsen J: Cognitive Impairment, Alzheimer’s Disease, and Other Dementias in the Lives of Lesbian, Gay, Bisexual and Transgender (LGBT) Older Adults and Their Caregivers: Needs and Competencies. J Appl Gerontol 2018, 37(5):545–569.
2. Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, Burke JR, Steffens DC, Foster NL, Giordani B, Unverzagt FW et al: Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol 2011, 70(3):418–426.
3. Pais R, Ruano L, O PC, Barros H: Global Cognitive Impairment Prevalence and Incidence in Community Dwelling Older Adults-A Systematic Review. Geriatrics (Basel) 2020, 5(4).
4. Arevalo-Rodriguez I, Smailagic N, Roque-Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S: Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2021, 7:CD010783.
5. Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189–198.
6. Baker FA, Bloska J, Braat S, Bukowska A, Clark I, Hsu MH, Kvamme T, Lautenschlager N, Lee YC, Smrokowska-Reichmann A et al: HOMESIDE: home-based family caregiver-delivered music and reading interventions for people living with dementia: protocol of a randomised controlled trial. Bmj Open 2019, 9(11):e031332.
7. Dye L, Boyle NB, Champ C, Lawton C: The relationship between obesity and cognitive health and decline. P Nutr Soc 2017, 76(4):443–454.
8. Hou QT, Guan Y, Yu WH, Liu XT, Wu LH, Xiao MZ, Lu Y: Associations between obesity and cognitive impairment in the Chinese elderly: an observational study. Clinical Interventions in Aging 2019, 14:367–373.
9. Nguyen JC, Killcross AS, Jenkins TA: Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci 2014, 8:375.
10. O’Brien PD, Hinder LM, Callaghan BC, Feldman EL: Neurological consequences of obesity. Lancet Neurol 2017, 16(6):465–477.
11. Zhang T, Yan R, Chen Q: Body mass index, waist-to-hip ratio and cognitive function among Chinese elderly: a cross-sectional study (vol 8, e022055, 2018). Bmj Open 2018, 8(11).
12. Yuan YM, Li J, Zhang N, Fu PP, Jing ZY, Yu CT, Zhao D, Hao WT, Zhou CC: Body mass index and mild cognitive impairment among rural older adults in China: the moderating roles of gender and age. Bmc Psychiatry 2021, 21(1).
13. Garcia-Ptacek S, Faxen-Irving G, Cermakova P, Eriksdotter M, Religa D: Body mass index in dementia. Eur J Clin Nutr 2014, 68(11):1204–1209.
14. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R: Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007, 64(3):392–398.
15. Deschamps V, Astier X, Ferry M, Rainfray M, Emeriau JP, Barberger-Gateau P: Nutritional status of healthy elderly persons living in Dordogne, France, and relation with mortality and cognitive or functional decline. Eur J Clin Nutr 2002, 56(4):305–312.
16. Kuo HK, Jones RN, Milberg WP, Tennstedt S, Talbot L, Morris JN, Lipsitz LA: Cognitive function in normal-weight, overweight, and obese older adults: an analysis of the Advanced Cognitive Training for Independent and Vital Elderly cohort. J Am Geriatr Soc 2006, 54(1):97–103.
17. Wang F, Zhao M, Han Z, Li D, Zhang S, Zhang Y, Kong X, Sun N, Zhang Q, Lei P: Association of body mass index with amnestic and non-amnestic mild cognitive impairment risk in elderly. Bmc Psychiatry 2017, 17(1):334.
18. Huang T, Chen Z, Shen L, Fan X, Wang K: Associations of Cognitive Function with BMI, Body Fat Mass and Visceral Fat in Young Adulthood. Medicina (Kaunas) 2019, 55(6).
19. Anand SS, Friedrich MG, Lee DS, Awadalla P, Despres JP, Desai D, de Souza RJ, Dummer T, Parraga G, Larose E et al: Evaluation of Adiposity and Cognitive Function in Adults. JAMA Netw Open 2022, 5(2):e2146324.
20. Zeki Al Hazzouri A, Haan MN, Whitmer RA, Yaffe K, Neuhaus J: Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord 2012, 33(6):400–409.
21. Kesse-Guyot E, Andreeva VA, Touvier M, Jeandel C, Ferry M, Hercberg S, Galan P, Grp SVMr: Overall and abdominal adiposity in midlife and subsequent cognitive function. J Nutr Health Aging 2015, 19(2):183–189.
22. Kanaya AM, Lindquist K, Harris TB, Launer L, Rosano C, Satterfield S, Yaffe K, Health ABCS: Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study. Arch Neurol 2009, 66(3):329–335.
23. West NA, Haan MN: Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study. J Gerontol A Biol Sci Med Sci 2009, 64(1):103–109.
24. Hermsdorff HHM, Zulet MA, Puchau B, Martinez JA: Central Adiposity Rather Than Total Adiposity Measurements Are Specifically Involved in the Inflammatory Status from Healthy Young Adults. Inflammation 2011, 34(3):161–170.
25. Koyama A, O’Brien J, Weuve J, Blacker D, Metti AL, Yaffe K: The role of peripheral inflammatory markers in dementia and Alzheimer’s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 2013, 68(4):433–440.
26. Chen CH, Yang JH, Chiang CWK, Hsiung CN, Wu PE, Chang LC, Chu HW, Chang J, Song IW, Yang SL et al: Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Human Molecular Genetics 2016, 25(24):5321–5331.
27. PK Yip, YI Shyu, SI Liu, JY Lee, CF Chou, RC CHEN, SH Lin, Chen R: An epidemiological survey of dementia among elderly in an urban district of Taipei. Acta Neurol Sinica 1992, 1:347–354.
28. Guo N-W, Liu H-C, Wong P-F, Liao K-K, Yan S-H, Lin K-P, Chang C-Y, Hsu T-C: Chinese Version and Norms of the Mini-Mental State Examination. J Rehab Med 1988, 16:52–59.
29. Katzman R, Zhang MY, Ouang Ya Q, Wang ZY, Liu WT, Yu E, Wong SC, Salmon DP, Grant I: A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 1988, 41(10):971–978.
30. Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M: Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol 1996, 3(3):198–202.
31. Pezzotti P, Scalmana S, Mastromattei A, Di Lallo D, Grp PAW: The accuracy of the MMSE in detecting cognitive impairment when administered by general practitioners: A prospective observational study. Bmc Fam Pract 2008, 9.
32. Li G, Shen YC, Chen CH, Zhao YW, Li SR, Lu M: An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 1989, 79(6):557–563.
33. Hugo J, Ganguli M: Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med 2014, 30(3):421–442.
34. Lin E, Kuo PH, Lin WY, Liu YL, Yang AC, Tsai SJ: An association study in the Taiwan Biobank elicits three novel candidates for cognitive aging in old adults: NCAM1, TTC12 and ZBTB20. Aging (Albany NY) 2021, 13(14):18769–18788.
35. Wang J, Xiao LD, Wang K, Luo Y, Li XM: Gender Differences in Cognitive Impairment among Rural Elderly in China. Int J Env Res Pub He 2020, 17(10):3724.
36. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289–300.
37. Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA et al: People with Parkinson’s Disease and Normal MMSE Score Have a Broad Range of Cognitive Performance. Movement Disord 2014, 29(10):1258–1264.
38. Kvitting AS, Fallman K, Wressle E, Marcusson J: Age-Normative MMSE Data for Older Persons Aged 85 to 93 in a Longitudinal Swedish Cohort. J Am Geriatr Soc 2019, 67(3):534–538.
39. Srikanthan P, Seeman TE, Karlamangla AS: Waist-Hip-Ratio as a Predictor of All-Cause Mortality in High-Functioning Older Adults. Ann Epidemiol 2009, 19(10):724–731.
40. Welborn TA, Dhaliwal SS: Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007, 61(12):1373–1379.
41. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L et al: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366(9497):1640–1649.
42. Guo DD, Zhang X, Zhan CQ, Lin QX, Liu J, Yang QX, Tu J, Ning XJ, Wang JH, Song YJ: Sex Differences in the Association Between Obesity and Cognitive Impairment in a Low-Income Elderly Population in Rural China: A Population-Based Cross-Sectional Study. Front Neurol 2021, 12.
43. Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, Ebmeier KP, Ferrie JE, Dugravot A: Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012, 344:d7622.
44. Lin WY, Wang YC, Teng IH, Liu C, Lou XY: Associations of five obesity metrics with epigenetic age acceleration: Evidence from 2,474 Taiwan Biobank participants. Obesity (Silver Spring) 2021, 29(10):1731–1738.
45. Cashdan E: Waist-to-Hip Ratio across Cultures: Trade-Offs between Androgen- and Estrogen-Dependent Traits. Curr Anthropol 2008, 49(6):1098–1106.
46. Westphal SA: Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008, 9(1):23–29; discussion 30 − 21.
47. Kim B, Feldman EL: Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med 2015, 47.
Metadata
Title
Associations of five obesity indicators with cognitive performance in 30,697 Taiwan Biobank participants
Author
Wan-Yu Lin
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03457-x

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue

Research

The association between frailty and dignity in community-dwelling older people

Research

Sleep characteristic profiles and the correlation with spectrum of metabolic syndrome among older adult: a cross-sectional study

Research

Assessment of dementia knowledge and its associated factors among final year medical undergraduates in selected universities across Malaysia

Research

The long-term prognostic value of serum 25(OH)D, albumin, and LL-37 levels in acute respiratory diseases among older adults

Research

Association between multimorbidity trajectories and incident disability among mid to older age adults: China Health and Retirement Longitudinal Study

Research

Implementing an intervention to reduce use of antibiotics for suspected urinary tract infection in nursing homes – a qualitative study of barriers and enablers based on Normalization Process Theory
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits